You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

XIMINO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ximino patents expire, and what generic alternatives are available?

Ximino is a drug marketed by Journey and is included in one NDA. There are six patents protecting this drug.

This drug has twelve patent family members in nine countries.

The generic ingredient in XIMINO is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ximino

A generic version of XIMINO was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for XIMINO?
  • What are the global sales for XIMINO?
  • What is Average Wholesale Price for XIMINO?
Summary for XIMINO
Drug patent expirations by year for XIMINO
Drug Prices for XIMINO

See drug prices for XIMINO

US Patents and Regulatory Information for XIMINO

XIMINO is protected by six US patents.

Patents protecting XIMINO

Minocycline oral dosage forms for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS

Minocycline oral dosage forms for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Minocycline oral dosage forms for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACNE

Method for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACNE

Minocycline oral dosage forms for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACNE

Minocycline oral dosage forms for the treatment of acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACNE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-001 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-005 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-002 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-001 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-003 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-005 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-003 Jul 11, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for XIMINO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-001 Jul 11, 2012 ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-003 Jul 11, 2012 ⤷  Sign Up ⤷  Sign Up
Journey XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-005 Jul 11, 2012 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for XIMINO

See the table below for patents covering XIMINO around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2007001961 ⤷  Sign Up
Australia 2006262428 Method for the treatment of acne ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2010017310 ⤷  Sign Up
Norway 20080444 ⤷  Sign Up
New Zealand 564093 Method for the treatment of acne using an oral minocycline antibiotic ⤷  Sign Up
China 101208097 Method for the treatment of acne ⤷  Sign Up
Japan 2013213047 METHOD FOR TREATMENT OF ACNE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.